Fidson Rights Issue Sees Strong Institutional Take-Up
Fidson Healthcare Plc delivered a decisive signal of shareholder confidence after its recently concluded rights issue closed oversubscribed at 117%, despite shareholders ultimately receiving only 85% allotment on additional subscriptions. Importantly, the company achieved full uptake of the rights on offer, underscoring strong capital market appetite for the pharmaceutical manufacturer.
The structure of participation, however, revealed a sharply concentrated ownership dynamic. Allocation data showed that the largest investors overwhelmingly dominated the exercise. The 100 million shares-and-above category, comprising just two applicants, secured 332 million allotted shares, approximately 55% of the entire issue.
When combined with the 10 million to 50 million shares bracket, where eight applicants received 154 million shares or roughly 26% of the total allotment, the top-tier investors effectively controlled over 80% of the shares distributed. The pattern points to aggressive participation from institutional investors, strategic insiders, and founder-linked interests determined to consolidate positions.
Retail participation was materially broader in number but marginal in scale. The 1,000 shares-and-above category accounted for 1,394 applicants, the single largest investor group by count, yet collectively received only 492,000 shares, representing less than 1% of total allotment. The disparity highlights the persistent imbalance between retail enthusiasm and institutional capital strength in Nigerian primary market transactions.
Demand for additional shares also materially exceeded supply. More than 2,200 shareholders applied for 152 million shares beyond their initial rights entitlement, but only 48 million additional shares were allotted, implying an effective pro-rata allocation of roughly 32%. The scale of rationing reinforces the depth of excess demand generated during the offer period.
Secondary market activity in the renounceable rights segment was equally notable. Thirteen shareholders traded approximately 334 million rights units valued at nearly N12 billion on the Nigerian Exchange, reflecting an active market for rights monetisation and position accumulation ahead of final allotment.
The pricing dynamics further strengthen the market’s interpretation of the transaction. With the rights issue priced at N35.00 per share against the stock’s current market price of N136.50, investors were effectively offered a deeply discounted entry point into the company.
The substantial gap between offer price and prevailing market valuation likely amplified institutional participation and intensified competition for additional allotments. Overall, the outcome reinforces two key market conclusions: first, confidence in Fidson’s long-term earnings and expansion trajectory remains robust among sophisticated investors; and second, capital raises of this nature in the Nigerian equities market continue to favor deep-pocketed participants capable of aggressively scaling exposure during oversubscribed offers. #Fidson Rights Issue Sees Strong Institutional Take-Up#
Nigeria’s Capital Market Enters Fast Lane as NGX Adopts T+1 Settlement Cycle
